Asahi Kasei offers pharmaceutical excipient Ceolus with nitrite concentration of 0.1 ppm or less
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
The plant will drive pharmaceutical innovation in the Northeastern India
Varenicline is indicated for smoking cessation in adults
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
These re-agent and diagnostic test kits come with 99.7% accuracy
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
Combines biocompatibility, heat-resistance, transparency and durability
Subscribe To Our Newsletter & Stay Updated